The Silent Threat: Tobacco-Nicotine Dependence

Tobacco Nicotine Dependence Syndrome (TNSS) is a complex condition characterized by addiction to nicotine. It significantly impacts individuals’ health, quality of life, and overall well-being. Accurate assessment of tobacco dependence is crucial for effective cessation interventions and improving patient outcomes.

The High Cost of Tobacco Addiction: A Burden on Individuals and Society

Tobacco addiction leads to a multitude of health problems, including cancer, heart disease, and respiratory illnesses. It imposes a significant economic burden on individuals, healthcare systems, and society as a whole. Effective cessation programs and tools are essential for reducing the prevalence of tobacco use and its associated health risks.

Kribado: Your Solution for Tobacco Cessation

Kribado is an innovative risk stratification and behavior setting device designed to address the challenges of tobacco cessation. By accurately assessing tobacco dependence levels, Kribado empowers healthcare providers to develop personalized treatment plans and monitor treatment progress.

This cutting-edge solution offers a non-invasive screening process that delivers instant insights, enabling efficient patient triage and resource allocation. Kribado’s user-friendly interface and streamlined data collection ensure accurate and reliable results.

Indigital Technologies: Your Partner in Tobacco Cessation

Indigital Technologies is a leading pharmaceutical business growth expert with a proven track record of success. Our 9-year journey has involved collaborating with 653 pharmaceutical brands across 8 countries, generating over 9700 crores in revenue.

We are committed to developing innovative solutions that address critical healthcare challenges. With over 200 COAs and expertise across 12 therapeutic areas, Kribado represents our dedication to improving patient lives.